Founded in 2006 and funded through a series of small business innovation research grants and subsequent contracts with the U.S. Government, Cantimer's initial focus has been on the design and development of hand-held devices for non-invasive measurement and monitoring of changes in human hydration status. Dehydration, and dehydration-related conditions such as hypotension, heat exhaustion, heat stroke, urinary tract infections, chronic constipation, kidney stone formation and kidney failure, cost Medicare, Medicaid and Private Health Insurers billions of dollars each year and have an immeasurable impact on the economy. Furthermore, hundreds of peer-reviewed articles published over the years point to the fact that water deficits barely beyond the sensation threshold of thirst can have dramatic effects on physical and cognitive performance.
The premise behind Cantimer's initial development effort is that if changes in hydration status can be accurately and conveniently measured, they can be actively managed. Cantimer plans to introduce a range of hydration measurement and monitoring devices for use in medical, athletic and home health settings.
Cantimer occupies a 20,000 sq. ft. facility in Menlo Park, California. The facility is equipped with state-of-the-art test and measurement equipment, 1,200 sq. ft. of wet laboratories, 5,000 sq. ft. of electronics development and clean room manufacturing space, as well as office and warehousing areas.
The Company's technology is protected by five patents that have issued and an additional six patents that are pending.
Cantimer's executive leadership includes:
- Ray Stewart, Ph.D., Interim CEO, CTO and Co-Founder
- Jim Reed, COO and Co-Founder
- Robin Stracey, Director
- A. Wayne Tamarelli, Board Member
- Christophe Perthuisot, Director
Cantimer also works with an extensive group of collaborators, consultants and world-class medical and scientific advisors.